bioMerieux Expected to Invest $100M, Emerald Automotive Close to Plant Site Selection, and Mizzou Chooses Stadium Contractor

bioMerieux - According to WhoLou sources billion dollar global biotechnology company bioMerieux, headquartered in France, intends to stake nearly $100 million in their Hazelwood campus over the next five years. bioMerieux U.S. operations are based in Durham, NC and the company also has a facility in Lombard, IL.

At their Hazelwood campus, which operates continuously and features six buildings, bioMerieux employs approximately 600 full-time employees including nearly 450 associates in operations and support, more than 100 engineers and microbiologists, and nearly 50 in commercial operations and global customer service.

bioMerieux specializes in in the field of in vitro diagnostics, the diagnosis of infectious diseases, and is active in the analysis of food, pharmaceuticals, and environmental samples to determine microbiological quality. bioMerieux has aggressively been expanding their presence in St. Louis since acquiring former McDonnell Douglas subsidiary Vitek Systems in 1988.